Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 4:56 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Ductal Breast Carcinoma in Situ, Breast Cancer, Stage I, Breast Cancer, Stage II, Breast Cancer, Stage III
Interventions: omega-3 fatty acid, placebo, Questionnaire administration; Dietary Supplement · Other · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 45 Years to 65 Years · Female only
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Resting Energy Expenditure, Thermogenesis, Brown Adipose Tissue
Interventions: Mirabegron, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Bloomington, Indiana

Conditions: Heat Intolerance, Heat Stress, Fatigue; Heat
Interventions: Antioxidant Berry Supplementation, Acute and Chronic Exercise-Heat Stress, Placebo (non-juice) Supplementation; Dietary Supplement · Other
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 50 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: AMD, nAMD, Wet Age-related Macular Degeneration, wAMD, Wet AMD, CNV, Neovascular AMD, Neovascular Age-related Macular Degeneration, Choroidal Neovascularization
Interventions: ABBV-RGX-314, Ranibizumab (LUCENTIS®); Genetic · Biological
Lead sponsor: AbbVie; Industry
Eligibility: 50 Years to 89 Years
Enrollment: 671 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 89
States / cities: Phoenix, Arizona • Sun City, Arizona • Little Rock, Arkansas + 77 more

Conditions: Sleep Disordered Breathing, Able Bodied
Interventions: Trazodone + positive airway pressure (PAP) therapy, Oxygen + positive airway pressure (PAP) therapy; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Pelvic Pain, Levator Ani Syndrome, Spastic Pelvic Floor Syndrome, Chronic Pelvic Pain Syndrome, Myalgia of Pelvic Floor
Interventions: SoLá therapy, Pelvic floor physical therapy; Device · Other
Lead sponsor: Orlando VA Medical Center; Federal
Eligibility: 18 Years and older · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Internet-based Intervention, Web-based Intervention, Online Intervention, Erectile Dysfunction, Telemedicine
Interventions: An automated patient-reported outcome data collection and adverse event surveillance tool; Other
Lead sponsor: Ro; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Type 1 Diabetes
Interventions: HIGH error, NO error, LOW error; Device
Lead sponsor: Joslin Diabetes Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypoxemia, Physiological Stress
Interventions: High-intensity interval exercise with surgical face mask in a temperate environment, High-intensity interval exercise with surgical face mask in a hot environment, High-intensity interval exercise without using a surgical face mask in a hot environment, High-intensity interval exercise without using a surgical face mask in a temperate environment; Device · Other
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Aging
Interventions: Hydration-Dehydration-Rehydration Protocol (HDR); Behavioral
Lead sponsor: Texas Tech University; Other
Eligibility: 45 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Multiple Sclerosis, Relapsing-Remitting, Sexual Dysfunction
Interventions: Behavioural intervention for physical activity for multiple sclerosis (BIPAMS); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Erectile Dysfunction Following Radical Prostatectomy, Urinary Incontinence of Non-organic Origin
Interventions: Viberect device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 70 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 2
States / cities: Baltimore, Maryland • Frederick, Maryland

Conditions: Autonomic Nervous System Imbalance, Hypothalamic Pituitary Adrenal Axis Suppression
Interventions: Active Music Therapy, Passive Music Therapy; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 34 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Erectile Dysfunction
Interventions: Shockwave therapy; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: High Blood Pressure, Liver Transplant, Renal Function Abnormal
Interventions: Amlodipine Besylate, Chlorthalidone; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Erectile Dysfunction, Benign Prostatic Hyperplasia
Interventions: Tadalafil, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 606 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 17
States / cities: Anchorage, Alaska • Phoenix, Arizona • La Mesa, California + 14 more

Conditions: Hematopoietic/Lymphoid Cancer
Interventions: fPER; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 85 Years
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Peripheral Neuropathy With Type 2 Diabetes
Interventions: Intraneural Facilitation Therapy Treatment, Standard Physical Therapy Treatment; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 45 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Augmented Reality
Interventions: Augmented Reality Headset; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG
Interventions: Virtual human social interaction, Cold pressor test; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Downey, California • Los Angeles, California

Conditions: Healthy
Interventions: Control, Whole Chickpeas, Puréed Chickpeas, 100% Chickpea Flour Product; Other
Lead sponsor: USDA Grand Forks Human Nutrition Research Center; Federal
Eligibility: 19 Years to 60 Years
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Grand Forks, North Dakota

Conditions: Low Back Pain, Back Pain Lower Back Chronic, Low Back Pain, Recurrent
Interventions: Acupuncture; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Achondroplasia
Interventions: BMN 111, Placebo; Drug
Lead sponsor: BioMarin Pharmaceutical; Industry
Eligibility: 5 Years to 18 Years
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 11
States / cities: Oakland, California • Torrance, California • Wilmington, Delaware + 8 more

Conditions: Sexual Dysfunction, Stem Cell Transplant Complications, Bone Marrow Transplant Complications
Interventions: SHIFT Intervention Group, Enhanced Usual Care Group; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 3
States / cities: Coral Gables, Florida • Boston, Massachusetts • Philadelphia, Pennsylvania

Search by objective public record fields.

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

MIrabegron and Physiological Function in Cold Environments

Acquiring and Targeting Heat Exposures Necessary for Action

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment

Photobiomodulation for Myofascial Pelvic Pain

Evaluating Treatment Continuation in Telehealth Patients Receiving an Automated Patient-Reported Outcome Tool

Effect of Gain on Closed-Loop Insulin

"Facemask Use During High-intensity Interval Exercise in Temperate and Hot Environments"

Dehydration, Rehydration, and Impact on Physiology

Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis

Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy

Active and Passive Music Therapy Interventions

A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction

Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia

Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distress

A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy

AR vs In Person Simulation for Medical Workplace Training

Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States

Pulse Revolution: Enhancing Metabolic Health Through the Power of Processed Chickpeas

Brain Imaging Study of Acupuncture in Chronic Low Back Pain

A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors